Shifting the focus in lymphoma treatment
The future of lymphoma treatment – combining new therapies with molecular diagnosis
How can clinicians and nurses care for patients with oral graft-versus-host disease (GvHD)?
The role of blinatumomab in ALL
Does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
Carmelo Carlo Stella